RecruitingPhase 4NCT07499804
Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Sponsor
Beni-Suef University
Enrollment
100 participants
Start Date
Oct 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
investigate the effect of different vasodilators as Tadalafil in women with unexplained infertility using IVF
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 43 Years
Inclusion Criteria1
- has good quality day five frozen embryos.
Exclusion Criteria2
- hypotension (blood pressure less than 90/50) and
- history of stroke or myocardial infarction
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGTadalafil 5mg
phosphodiesterase type 5 (PDE-5) inhibitor
DRUGestradiol valerate 2 mg
estradiol valerate 2 mg. in form of (Cycloprogynova® Bayer Shering Pharma) white pills starting dose is one pill T.I.D may be increased to two pills T.I.D according to endometrial thickness in day 9 measured by vaginal ultrasound.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07499804
Related Trials
Impact of a Mindfulness Intervention on Infertile Women Undergoing Assisted Reproductive Technique Treatments
NCT044197401 location
Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes
NCT074998171 location
Identification of Biomarkers in Cervical Mucus
NCT067714011 location
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
NCT0620674623 locations
Biomarkers of Endometrial Receptivity
NCT046195243 locations